Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04621019
Other study ID # BTL-785F_ABL
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 11, 2021
Est. completion date January 26, 2023

Study information

Verified date April 2023
Source BTL Industries Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with BTL-785-1 applicator for non-invasive lipolysis (breakdown of fat) of the abdomen and reduction in circumference of the abdomen. Safety measures will include documentation of adverse events (AE) during and after the procedures. Follow-ups visits at 1 month and 3 months after the final treatment will be held.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date January 26, 2023
Est. primary completion date November 8, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Healthy male or female subjects over 21 years of age seeking treatment for abdominal circumference reduction - Subjects should be able understand the investigative nature of the treatment, the possible benefits and side effects, and must sign the Informed Consent Form - Presence of clearly visible fat deposits in the abdominal area as deemed appropriate by the Investigator (e.g. by pinch test or ultrasound fat thickness measurement) - Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation. - No procedure for abdominal fat reduction (including cellulite treatment) in the last six months. - Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting a significant change of weight in either direction during study participation. - Willingness to comply with study instructions and to return to the clinic for required visits. Exclusion Criteria: - Bacterial or viral infection, acute inflammations - Impaired immune system - Isotretinoin use in the past 12 months - Skin related autoimmune diseases - Radiation therapy and/or chemotherapy - Poor healing and unhealed wounds in the treatment area - Metal implants - Permanent implant in the treated area - Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body - Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles - History of any type of cancer - Active collagen diseases - Cardiovascular diseases (such as vascular diseases, peripheral arterial disease, thrombophlebitis and thrombosis) - Pregnancy/nursing or IVF procedure - History of bleeding coagulopathies, use of anticoagulants - Any active condition in the treatment area, such as sores, psoriasis, eczema, etc. - Any surgical procedure in the treatment area within the last three months or before complete healing - Poorly controlled endocrine disorders, such as diabetes - Acute neuralgia and neuropathy - Kidney or liver failure - Sensitivity disorders in the treatment area - Varicose veins, pronounced edemas - Previous liposuction in the treatment area in the last six months - Unstable weight within the last 6 months (change in weight ± 3%) - Previous body contouring or cellulite treatments in the abdominal area in the last six months - Any other disease or condition (e.g. hernia) at the investigator discretion that may pose risk to the patient or compromise the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BTL-785F
Treatment with study device.

Locations

Country Name City State
Bulgaria Ambulatory for Individual Practice for Specialized Outpatient Medical Care in Dermatology and Venereology Dr. Ivelina Yordanova-Vasileva Pleven
Bulgaria Dr. Lekova Derm Ltd. Sofia

Sponsors (1)

Lead Sponsor Collaborator
BTL Industries Ltd.

Country where clinical trial is conducted

Bulgaria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Statistically significant reduction of abdominal fat thickness determined with ultrasound To gather clinical evidence that BTL-785F system equipped with BTL-785-1 applicator is able to provide statistically significant reduction of at least 1,5 cm at the 3-months follow-up compared to baseline with a minimum response rate of 65% in both abdominal circumference and fat thickness. 5 months
Secondary Evaluation of the safety of the BTL-785F device with BTL-785-1 applicator for non-invasive lipolysis and circumference reduction of the abdomen At every treatment visit after the first, prior to the procedure, the participants will be assessed for adverse effects resulting from the previous treatment(s) with the BTL-785F device.
Safety measures will include documentation of adverse events (AE) during and after the procedures.
5 months
Secondary Assessment of the participants' satisfaction from the therapy measured via standard questionnaire Minimum 80% of treated subjects to report satisfaction (level satisfied and higher) with the therapy; 5 months
See also
  Status Clinical Trial Phase
Completed NCT04599257 - Fat Reduction and Muscle Toning of Thighs N/A
Completed NCT05580263 - Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. N/A
Completed NCT04643275 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms N/A
Completed NCT05139745 - Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue N/A
Completed NCT05975489 - Genetics in the Effect of Caffeine on Fat Oxidation N/A
Completed NCT04696614 - Testing the Effect of Exercise Intervention Using a SMART Design. N/A
Completed NCT04455009 - Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism N/A
Completed NCT05260164 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Flanks N/A
Recruiting NCT05261373 - Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 Diabetics N/A
Recruiting NCT04043182 - EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT N/A
Completed NCT04587804 - Abdomen - Fat Reduction and Muscle Toning N/A
Completed NCT05540080 - Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen N/A
Completed NCT04587986 - rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat N/A
Active, not recruiting NCT06274177 - Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation N/A
Completed NCT06282172 - Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue N/A
Not yet recruiting NCT03357601 - High Intensity Interval Training vs Moderate Continuous Endurance Exercise Training on Program Adherence N/A
Completed NCT05215275 - Comparison of Different Exercise Trainings on Heart Rate Variability N/A
Completed NCT03811093 - Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss N/A
Active, not recruiting NCT06333496 - Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans N/A
Not yet recruiting NCT06219850 - Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study